Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -145459.36% is 829% below its 1-year average of -15660.92%, near the low end of its 1-year range (-145459.36%–0.00%).
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
-145459.36%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
N/A
OPERATING MARGIN AVG 5Y
N/A
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 713 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Neonc Technologies Holdings, Inc.
Market Cap
$77.54M
Operating Margin
-145459.36%
TTM Avg
0.00%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$76.19M
Operating Margin
-273.43%
TTM Avg
-304.38%
3Y Avg
-532.26%
5Y Avg
-2409.22%
Market Cap
$76.19M
Operating Margin
-56.06%
TTM Avg
-77.78%
3Y Avg
-106.34%
5Y Avg
-131.30%
Market Cap
$79.46M
Operating Margin
-132871.32%
TTM Avg
-92244.12%
3Y Avg
-51098.97%
5Y Avg
-37173.74%
Market Cap
$80.04M
Operating Margin
-52.96%
TTM Avg
-64.09%
3Y Avg
-81.91%
5Y Avg
-87.35%
Market Cap
$74.43M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-13254.09%
5Y Avg
-12240.62%
Market Cap
$81.45M
Operating Margin
-408.41%
TTM Avg
-360.51%
3Y Avg
-288.53%
5Y Avg
-284.25%
Market Cap
$82.53M
Operating Margin
-42.06%
TTM Avg
-31.00%
3Y Avg
-37.02%
5Y Avg
-45.87%
Market Cap
$82.73M
Operating Margin
-3242.47%
TTM Avg
-1621.23%
3Y Avg
-1058.13%
5Y Avg
-747.59%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Neonc Technologies Holdings, Inc. (NTHI) | $77.54M | -145459.36% | 0.00% | N/A | N/A |
| Hyperfine, Inc. (HYPR)vs › | $76.19M | -273.43% | -304.38% | -532.26% | -2409.22% |
| Outset Medical, Inc. (OM)vs › | $76.19M | -56.06% | -77.78% | -106.34% | -131.30% |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $79.46M | -132871.32% | -92244.12% | -51098.97% | -37173.74% |
| Pulmonx Corporation (LUNG)vs › | $80.04M | -52.96% | -64.09% | -81.91% | -87.35% |
| Gain Therapeutics, Inc. (GANX)vs › | $74.43M | 0.00% | 0.00% | -13254.09% | -12240.62% |
| Nutriband Inc. (NTRB)vs › | $81.45M | -408.41% | -360.51% | -288.53% | -284.25% |
| LENSAR Inc (LNSR)vs › | $82.53M | -42.06% | -31.00% | -37.02% | -45.87% |
| MediciNova, Inc. (MNOV)vs › | $82.73M | -3242.47% | -1621.23% | -1058.13% | -747.59% |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $82.82M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
100.0%
Operating Margin
-145459.4%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | -93965.52% |
